还有另外一些对麦利亚德公司的批评。
One is that its patents are too broad.
有人认为麦利亚德公司的专利涵盖范围过大。
The firm s tests look for variations in BRCA genes.
该公司的基因测序是为发现BRCA基因的突变体。
Rather than patenting every conceivable variant, the company claims jurisdiction overisolated DNA sequences, 15 base pairs long, that match short parts of the genes.
他们不是对每一有可能得到的基因突变体持有专利权,而是对一段分离到的基因序列持有专利权,这段基因序列含有15个碱基对,可与BRCA基因短链配对。
An analysis by Jeffrey Rosenfeld and Christopher Mason, of the Sackler Institute forComparative Genomics and Cornell University respectively, published in Genome Medicine,found that 689 other human genes contain 15-base-pair strings found in BRCA1,suggesting Myriad s patents technically cover those unrelated genes, too.
分别来自赛克勒比较基因组学研究所和康奈尔大学的杰弗里罗森菲尔德以及克里斯托弗梅森,在《Genome Medicine》杂志发表的文章中指出,研究发现其他689个人类基因都含有BRCA1基因中的这段15个碱基对的DNA链,这表明麦利亚德公司的专利从学术角度来讲也涵盖这些不相关的基因。
【2015考研英语阅读生物技术专利】相关文章:
最新
2016-10-18
2016-10-11
2016-10-11
2016-10-08
2016-09-30
2016-09-30